British company Rem3dy Health has closed a £14 million (approx. $18.8 million) funding round to finance its international growth. The capital was raised through a Simple Agreement for Future Equity (SAFE), with the final commitments received earlier this year and converted into shares this month. The round values the Birmingham-headquartered business at £84 million. The…